Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care), slated to be listed on the main market (TASI), posted a net profit of SAR 279.6 million for 2023, down 14% from SAR 326.3 million a year earlier.
Item | 2022 | 2023 | Change |
---|---|---|---|
Revenues | 2,012.39 | 2,326.69 | 15.6 % |
Gross Income | 612.25 | 616.68 | 0.7 % |
Operating Income | 369.69 | 312.84 | (15.4 %) |
Net Income | 326.32 | 279.59 | (14.3 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 1.63 | 1.40 | (14.3 %) |
The profit decline was attributed to a 32% year-on-year (YoY) rise in operating expenses to SAR 292.5 million. Financing costs also increased to SAR 122.2 million, while gross profit margin declined to 27% compared with 30% a year earlier. The operating profit margin fell to 13% in 2023, versus 18% a year ago.
However, revenues surged to SAR 2.32 billion in 2023 as other income also grew to SAR 25.8 million by year-end. Further, Financing revenues went up to SAR 38.2 million during the same year.
In Q4 2023, net earnings dropped 30% to SAR 74 million, compared with SAR 104.91 million in the same period of 2022.
On a quarter-on-quarter basis, net earnings decreased 7.1% from SAR 79.65 million in Q3 2023.
Item | Q4 2022 | Q4 2023 | Change |
---|---|---|---|
Revenues | 540.37 | 662.32 | 22.6 % |
Gross Income | 176.32 | 182.10 | 3.3 % |
Operating Income | 97.59 | 79.73 | (18.3 %) |
Net Income | 104.91 | 73.99 | (29.5 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.52 | 0.37 | (29.5 %) |
Item | Q3 2023 | Q4 2023 | Change |
---|---|---|---|
Revenues | 589.29 | 662.32 | 12.4 % |
Gross Income | 173.37 | 182.10 | 5.0 % |
Operating Income | 96.08 | 79.73 | (17.0 %) |
Net Income | 79.65 | 73.99 | (7.1 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.40 | 0.37 | (7.1 %) |
Total shareholders' equity, after minority interest, reached SAR 1.02 billion at the end of December 2023, compared with SAR 1.89 billion a year before.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}